Skip to content
CERT·Nasdaq·US

Certara

Certara is a biosimulation and drug-development software company that sells predictive modeling tools, regulatory software, and related consulting services to pharmaceutical, biotechnology, and medical device customers. Its products are used to support discovery, clinical development, dose optimization, and regulatory submissions.

Thematic Position

CERT

Relationship Groups

Partners1
Competitors3

Relationship details are part of the Pro plan.

Ended Relationships

1 ended relationship · Ended relationships are part of the Pro plan.

Management Perspective on Regulatory & Geopolitical Developments

drug pricing regulationgovernment funding policy
US executive actions on drug pricing create demand uncertainty for biopharma customers
SEC 10-KFeb 26, 2026

The full regulatory passage is part of the Pro plan.

10 more · Regulatory and geopolitical insights are part of the Pro plan.